Back to search
FDAFDA · Food and drugs·Recall number D-0387-2026

MAXIMUM, ZONE 2, 4% Lidocaine Cream, (Lidocaine 4% and Epinephrine 0.01%), 1 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-015.

Published March 11, 2026 · Recall initiated: February 18, 2026

Summary

FDA records drug Class II recall D-0387-2026, published March 11, 2026 and initiated February 18, 2026. Recalling firm: HTO Nevada Inc. dba Kirkman; Status: Ongoing; Reported quantity: 243 bottles; Lot: Lot #: 795CP-0005, Exp. Date 06/30/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Stability Data Does Not Support Expiry Date.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
HTO Nevada Inc. dba Kirkman
Distributor
Nationwide within the U.S
Lot
Lot #: 795CP-0005, Exp. Date 06/30/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was MAXIMUM, ZONE 2, 4% Lidocaine Cream, (Lidocaine 4% and Epinephrine 0.01%), 1 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-015. recalled?

Yes. FDA published recall D-0387-2026 on March 11, 2026. Reported hazard: Stability Data Does Not Support Expiry Date.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail